Chip based Neurovascular Model for Neuroprosthetics

Information

  • Research Project
  • 8679017
  • ApplicationId
    8679017
  • Core Project Number
    R21NS077285
  • Full Project Number
    5R21NS077285-02
  • Serial Number
    077285
  • FOA Number
    PA-11-261
  • Sub Project Id
  • Project Start Date
    6/15/2013 - 10 years ago
  • Project End Date
    5/31/2015 - 9 years ago
  • Program Officer Name
    LAVAUTE, TIMOTHY M
  • Budget Start Date
    6/1/2014 - 10 years ago
  • Budget End Date
    5/31/2015 - 9 years ago
  • Fiscal Year
    2014
  • Support Year
    02
  • Suffix
  • Award Notice Date
    6/13/2014 - 9 years ago

Chip based Neurovascular Model for Neuroprosthetics

DESCRIPTION (provided by applicant): Reliable performance of neural recording electrodes continues to be a very significant hurdle in successful clinical application of neuroprosthetics. Although progressive astrocytic encapsulation and neuronal loss/degeneration have been implicated as principal mechanisms of neuroelectrode failure, recent work has found evidence that persistent inflammation and neurovascular (BBB) compromise may have a more significant role than previously understood. Supplementing animal models, we propose to use a novel microfabricated device that recapitulates essential functions of the neurovascular unit, enabling the study of tissue response in a controlled fashion and the role of neuroinflammation after probe implantation. Our concept features a neural parenchyma (3-D mixture of neurons, astrocytes, and microglia) in communication with microvascular endothelial cells exposed to flow. In preliminary work we have successfully fabricated test devices, characterized barrier properties, and neuroglial-vascular communication within the device. The first aim will quantitatively assess the tissue reaction to two different probes and validate the model response using known in vivo data. In the second aim, we will provide proof-of-principle and preliminary insights on the dynamic interplay of neuroinflammation and glial encapsulation, using circulating monocytes and anti- inflammatories. Our long term objective is to develop an automated instrument for mechanistic understanding and screening of novel probe designs, with general applicability towards other CNS disorders.

IC Name
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
  • Activity
    R21
  • Administering IC
    NS
  • Application Type
    5
  • Direct Cost Amount
    123750
  • Indirect Cost Amount
    94844
  • Total Cost
    218594
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    853
  • Ed Inst. Type
  • Funding ICs
    NINDS:218594\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    BNVT
  • Study Section Name
    Bioengineering of Neuroscience, Vision and Low Vision Technologies Study Section
  • Organization Name
    CHARLES STARK DRAPER LABORATORY
  • Organization Department
  • Organization DUNS
    066587478
  • Organization City
    CAMBRIDGE
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    021393539
  • Organization District
    UNITED STATES